Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Amy B. Heimberger

1-25 of 25 results

Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma

scientific article published on 23 December 2019

Rethinking medulloblastoma from a targeted therapeutics perspective

scientific article published on 05 June 2018

Multiplatform profiling of meningioma provides molecular insight and prioritization of drug targets for rational clinical trial design

scientific article published on 30 May 2018

Supplementary Fig. S2 from Perivascular NOTCH3<sup>+</sup> Stem Cells Drive Meningioma Tumorigenesis and Resistance to Radiotherapy

Supplementary Fig. S12 from Perivascular NOTCH3<sup>+</sup> Stem Cells Drive Meningioma Tumorigenesis and Resistance to Radiotherapy

Supplementary Fig. S1 from Perivascular NOTCH3<sup>+</sup> Stem Cells Drive Meningioma Tumorigenesis and Resistance to Radiotherapy

Supplementary Fig. S7 from Perivascular NOTCH3<sup>+</sup> Stem Cells Drive Meningioma Tumorigenesis and Resistance to Radiotherapy

Perivascular NOTCH3+ Stem Cells Drive Meningioma Tumorigenesis and Resistance to Radiotherapy

Replication stress response defects are associated with response to immune checkpoint blockade in nonhypermutated cancers

scientific article published on 27 October 2021

Supplementary Fig. S15 from Perivascular NOTCH3<sup>+</sup> Stem Cells Drive Meningioma Tumorigenesis and Resistance to Radiotherapy

Supplementary Fig. S13 from Perivascular NOTCH3<sup>+</sup> Stem Cells Drive Meningioma Tumorigenesis and Resistance to Radiotherapy

Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade

Supplementary Fig. S9 from Perivascular NOTCH3<sup>+</sup> Stem Cells Drive Meningioma Tumorigenesis and Resistance to Radiotherapy

Supplementary Fig. S16 from Perivascular NOTCH3<sup>+</sup> Stem Cells Drive Meningioma Tumorigenesis and Resistance to Radiotherapy

Supplementary Fig. S8 from Perivascular NOTCH3<sup>+</sup> Stem Cells Drive Meningioma Tumorigenesis and Resistance to Radiotherapy

Supplementary Fig. S10 from Perivascular NOTCH3<sup>+</sup> Stem Cells Drive Meningioma Tumorigenesis and Resistance to Radiotherapy

ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma

Supplementary Fig. S3 from Perivascular NOTCH3<sup>+</sup> Stem Cells Drive Meningioma Tumorigenesis and Resistance to Radiotherapy

Supplementary Fig. S6 from Perivascular NOTCH3<sup>+</sup> Stem Cells Drive Meningioma Tumorigenesis and Resistance to Radiotherapy

B7-H3 Specific CAR T Cells for the Naturally Occurring, Spontaneous Canine Sarcoma Model

scientific article published in 2022

FGL2-wired macrophages secrete CXCL7 to regulate the stem-like functionality of glioma cells

scientific article published in 2021

Supplementary Fig. S4 from Perivascular NOTCH3<sup>+</sup> Stem Cells Drive Meningioma Tumorigenesis and Resistance to Radiotherapy

Supplementary Tables S1-S6 from Perivascular NOTCH3<sup>+</sup> Stem Cells Drive Meningioma Tumorigenesis and Resistance to Radiotherapy

Supplementary Fig. S5 from Perivascular NOTCH3<sup>+</sup> Stem Cells Drive Meningioma Tumorigenesis and Resistance to Radiotherapy

Blood-brain barrier opening with low intensity pulsed ultrasound for immune modulation and immune therapeutic delivery to CNS tumors

scientific article published on 28 February 2020